Skip to content

Submissions to Payers

As each payer has distinct requirements and decision-making considerations, submissions must be strategically tailored to address their specific needs.

  • CDA-AMC
  • INESSS
  • Provincial Plans
  • Private Insurers

We build robust reimbursement submissions for Canadian payers, leveraging strategic gap assessments, rigorous clinical and economic evidence, and payer-specific supporting documentation.

  • Proven Track Record – We have supported high-quality reimbursement submissions that have contributed to positive payer recommendations across multiple therapeutic areas.
  • Deep Expertise in the Canadian HTA Landscape – Our team brings more than 20 years of experience and in-depth knowledge of Canada’s evolving HTA environment.
  • Turnkey, Strategy-Driven Approach – From submission strategy and evidence generation to the integration of patient input, we bring together the evidence needed to build a compelling reimbursement submission dossier.
  • Tailored Approach – We adapt our approach to your needs and bring together the expertise required to address the full spectrum of your market access strategy.
A PeriPharm partner smiling during a discussion with a client across a meeting table